News Detail
Melbourne, 31 Oct 2024: An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resist......
View Details
Source : The Peter Doherty Institute for Infection and Immunity
liver disease
rifaximin
antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE)
VRE
Related News
- Police caught expired cosmetic goods in Meerut, DI denied action (09-11-2024)
- Sanitary napkins, baby diapers will now need BIS certification (09-11-2024)
- New Recruitment Rules for Medical Device Regulatory Positions (09-11-2024)
- Accused caught with 400 Pregabalin capsule handed over to DCO for further action (09-11-2024)
- Telangana DCA seize narcotic drugs, psychotropic substances from private hospitals (09-11-2024)
- Govt launches Rs 500 crore scheme to strengthen medical device industry (09-11-2024)
- Baddi firm asked to stop narcotic drug production amid CID probe (09-11-2024)
- Mohali police bust unit producing fake medicine (09-11-2024)
- Delhi HC restrains Aquakind labs from using 'AQUAKIND' trademark (09-11-2024)
- MBBS from abroad, started practicing medicine without passing FMGE, Registrations cancelled (08-11-2024)